- RecruitingPHASE2
Liquid-biopsy Informed Platform Trial to Evaluate CDK4/6-inhibitor Resistant ER+/HER2- Metastatic Breast Cancer
This study looks at new ways to treat advanced breast cancer that has stopped responding to standard treatments. By checking your blood or tumour for specific signs, doctors hope to find the best treatment for you, exploring several new drugs and combinations.
For: Breast CancerCanada - Active not recruitingPHASE2
CFI-400945 in Patients With Advanced/Metastatic Breast Cancer
This study is testing a new drug, CFI-400945, for advanced breast cancer in women. It's for patients who have already had chemotherapy, and researchers want to see if this new drug can help slow down cancer growth or shrink tumours.
For: Breast CancerCanada